Suppr超能文献

雌激素受体(ER)调节剂各自在雌激素受体α和雌激素受体β中诱导不同的构象变化。

Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta.

作者信息

Paige L A, Christensen D J, Grøn H, Norris J D, Gottlin E B, Padilla K M, Chang C Y, Ballas L M, Hamilton P T, McDonnell D P, Fowlkes D M

机构信息

Novalon Pharmaceutical Corporation, 4222 Emperor Boulevard, Suite 560, Durham, NC 27703, USA.

出版信息

Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3999-4004. doi: 10.1073/pnas.96.7.3999.

Abstract

Estrogen receptor (ER) modulators produce distinct tissue-specific biological effects, but within the confines of the established models of ER action it is difficult to understand why. Previous studies have suggested that there might be a relationship between ER structure and activity. Different ER modulators may induce conformational changes in the receptor that result in a specific biological activity. To investigate the possibility of modulator-specific conformational changes, we have applied affinity selection of peptides to identify binding surfaces that are exposed on the apo-ERs alpha and beta and on each receptor complexed with estradiol or 4-OH tamoxifen. These peptides are sensitive probes of receptor conformation. We show here that ER ligands, known to produce distinct biological effects, induce distinct conformational changes in the receptors, providing a strong correlation between ER conformation and biological activity. Furthermore, the ability of some of the peptides to discriminate between different ER alpha and ER beta ligand complexes suggests that the biological effects of ER agonists and antagonists acting through these receptors are likely to be different.

摘要

雌激素受体(ER)调节剂会产生不同的组织特异性生物学效应,但在既定的ER作用模型范围内,很难理解其原因。先前的研究表明,ER结构与活性之间可能存在关联。不同的ER调节剂可能会诱导受体的构象变化,从而产生特定的生物学活性。为了研究调节剂特异性构象变化的可能性,我们应用了肽的亲和选择来识别在无配体的ERα和ERβ以及与雌二醇或4-羟基他莫昔芬复合的每种受体上暴露的结合表面。这些肽是受体构象的敏感探针。我们在此表明,已知会产生不同生物学效应的ER配体可诱导受体产生不同的构象变化,这在ER构象与生物学活性之间提供了很强的相关性。此外,一些肽区分不同的ERα和ERβ配体复合物的能力表明,通过这些受体起作用的ER激动剂和拮抗剂的生物学效应可能不同。

相似文献

4
Peptide antagonists of the human estrogen receptor.人雌激素受体的肽拮抗剂。
Science. 1999 Jul 30;285(5428):744-6. doi: 10.1126/science.285.5428.744.

引用本文的文献

本文引用的文献

8
Mechanisms of cardioprotection by estrogens.
Proc Soc Exp Biol Med. 1998 Jan;217(1):23-9. doi: 10.3181/00379727-217-44201.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验